{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:47:08Z","timestamp":1791229628815,"version":"4.1.0"},"reference-count":58,"publisher":"Informa UK Limited","issue":"10","license":[{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2023,8,24]]},"DOI":"10.1080\/10428194.2023.2234528","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T11:22:57Z","timestamp":1691407377000},"page":"1643-1654","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Comparative effectiveness of salvage chemotherapy regimens and chimeric antigen T-cell receptor therapies in relapsed and refractory diffuse large B cell lymphoma: a network meta-analysis of clinical trials"],"prefix":"10.1080","volume":"64","author":[{"given":"Inna Y.","family":"Gong","sequence":"first","affiliation":[{"name":"Department of Radiation Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Aminilari","sequence":"additional","affiliation":[{"name":"Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Landego","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Hueniken","sequence":"additional","affiliation":[{"name":"Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7483-0478","authenticated-orcid":false,"given":"Qianghua","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6117-320X","authenticated-orcid":false,"given":"John","family":"Kuruvilla","sequence":"additional","affiliation":[{"name":"Department of Radiation Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4687-4582","authenticated-orcid":false,"given":"David C.","family":"Hodgson","sequence":"additional","affiliation":[{"name":"Department of Radiation Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,8,7]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21357"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011795"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2010.00737.x"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy203"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.3747\/co.26.5421"},{"issue":"4","key":"e_1_3_4_7_1","first-page":"232","article-title":"Relapsed\/refractory diffuse large B-cell lymphoma","volume":"10","author":"Ladicka M.","year":"2015","unstructured":"Ladicka M. Relapsed\/refractory diffuse large B-cell lymphoma. Onkologia (Bratislava). 2015;10(4):232\u2013235.","journal-title":"Onkologia (Bratislava)"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.366"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.1618"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdg702"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-11-3911"},{"key":"e_1_3_4_12_1","first-page":"3684","volume-title":"J Clin Oncol","author":"Crump M","year":"2014","unstructured":"Crump M, Kuruvilla J, Couban S, et\u00a0al. Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY. 12. J Clin Oncol. 2014;103(10):3684\u20133688."},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.56.100"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-017-0382-1"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2011.1.498"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-769620"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116133"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00662-6"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804980"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-4-1"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-8-16"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1045"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-017-0473-z"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.03.016"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v106.i02"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.07.015"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2017.10.005"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/0962280207080643"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.63572"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-02-699520"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLML.2010.n.017"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2818"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1007504"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.69.0198"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30026-2"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00172"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.9453"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14820"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70212-7"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16255"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27418"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-108415"},{"issue":"22","key":"e_1_3_4_44_1","first-page":"3206","article-title":"Ligustrazine as a salvage agent for patients with relapsed or refractory non-Hodgkin\u2019s lymphoma","volume":"123","author":"Yang X-G","year":"2010","unstructured":"Yang X-G, Jiang C. Ligustrazine as a salvage agent for patients with relapsed or refractory non-Hodgkin\u2019s lymphoma. Chin Med J (Engl). 2010;123(22):3206\u20133211.","journal-title":"Chin Med J (Engl)"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116596"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14731"},{"issue":"6","key":"e_1_3_4_47_1","first-page":"0897","article-title":"Prognosis and safety of rituximab combined with GDP regime for patients with relapsed diffuse large B-cell lymphoma","volume":"8","author":"Muhebaier AA","year":"2018","unstructured":"Muhebaier AA, Liu H, Guzailinuer MM, et\u00a0al. Prognosis and safety of rituximab combined with GDP regime for patients with relapsed diffuse large B-cell lymphoma. Anti-Tumor Pharm. 2018;8(6):0897\u20130902.","journal-title":"Anti-Tumor Pharm"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.4155\/fsoa-2018-0049"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01507-7"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26904"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.150111"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-018-0073-7"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-114152"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2016.10.020"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512073332305"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003531"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015789"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01144-9"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2023.2234528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T13:26:06Z","timestamp":1707398766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2023.2234528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,7]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,8,24]]}},"alternative-id":["10.1080\/10428194.2023.2234528"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2023.2234528","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,7]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-04-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}